Twist Bioscience–JPMorgan Chase: investor conference, 202401 supply service Twist Bioscience presents at JP Morgan Healthcare Conference 2024

	Period	2024-01-08
	Region	San Francisco, CA
	Country	United States (USA)
	Partner, 1st	Twist Bioscience Corporation (Nasdaq: TWST)
	Group	Twist Bioscience (Group)
	Partner, 2nd	J.P. Morgan Securities LLC
	Group	JPMorgan Chase (Group)
	Product	J.P. Morgan 42nd Annual Healthcare Conference 2024 San Francisco
	Product 2	synthetic biotechnology
	Person	LeProust, Emily M. (Twist Bioscience 2013– CEO + Co-Founder before Agilent Director Genomics Application Development)
	Person 2	Bitting, Angela (Twist Bioscience 202002 Media Contact)

Twist Bioscience Corporation. (12/18/23). "Press Release: Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference". South San Francisco, CA.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8 at 5:15 p.m. Pacific Time in San Francisco, CA.

The presentation will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

For Investors:

Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com

For Media:

Amanda Houlihan
Communications Generalist
774-265-5334
ahoulihan@twistbioscience.com